The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

12% of individuals receiving cardiac device implants develop persistent opioid use, according to a Penn Medicine study. 

All comments eligible for publication in Daily Pennsylvanian, Inc. publications.